Merck & Co., Inc. (MRK) Tops Q2 EPS by 4c

July 27, 2012 7:00 AM EDT
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $1.05, $0.04 better than the analyst estimate of $1.01. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $12.16 billion.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities